Alithea Genomics is a biotechnology company focused on revolutionizing drug discovery and toxicology through its proprietary RNA sequencing technology. Their platform enables industrial-scale RNA sequencing, making it more accessible and efficient for primary drug screening and toxicity assessments. This allows for faster identification of potential drug candidates and a more comprehensive understanding of their safety profiles.